Evotec stock at EUR 2.87 ahead of the Xetra open: biotech group slightly lower
Published on 10/28/2026 at 07:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey facts at a glance
- Evotec researches and develops drugs with partners using data-driven technologies and disease models.
- Germany's benchmark index is the DAX for October 28, 2026.
- Evotec stock trades pre-market at EUR 2.87 at 7:36 a.m. CET at Lang & Schwarz on October 28, 2026, 0.35 percent below the Xetra close of October 27, 2026.
Evotec researches and develops drugs with partners using data-driven technologies, molecular patient data and disease models, according to the company's Investor Relations information. Evotec stock trades pre-market at EUR 2.87 at 7:36 a.m. CET at Lang & Schwarz on October 28, 2026, 0.35 percent below the Xetra close of October 27, 2026 (EUR 2.88).
Pre-market indication
The indication is minus EUR 0.01 against that Xetra reference. The bid is EUR 2.85 and the ask is EUR 2.89, a spread of 1.39 percent that indicates thin pre-market trading. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Evotec stock.
Trading-day context
Evotec's work combines drug research and development with partner collaborations, data-driven technologies and activities designed to support the progression of medicines toward patients. Market context: Market report DAX.
